Aperam (APEMY)
(Delayed Data from OTC)
$25.34 USD
0.00 (0.00%)
Updated Sep 9, 2024 12:16 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Income Statements
Fiscal Year end for Aperam falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 7,135 | 8,593 | 6,036 | 4,140 | 4,749 |
Cost Of Goods | 6,724 | 7,350 | 4,577 | 3,719 | 4,304 |
Gross Profit | 410 | 1,243 | 1,459 | 420 | 445 |
Selling & Adminstrative & Depr. & Amort Expenses | 314 | 306 | 226 | 193 | 213 |
Income After Depreciation & Amortization | 96 | 938 | 1,233 | 227 | 232 |
Non-Operating Income | 30 | -1 | -1 | -1 | 1 |
Interest Expense | 0 | 144 | -2 | -46 | 26 |
Pretax Income | 127 | 792 | 1,234 | 272 | 207 |
Income Taxes | -94 | 133 | 88 | 72 | 41 |
Minority Interest | 1 | 1 | 1 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 221 | 660 | 1,146 | 200 | 166 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 220 | 659 | 1,145 | 200 | 166 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 317 | 1,134 | 1,403 | 392 | 400 |
Depreciation & Amortization (Cash Flow) | 221 | 196 | 170 | 164 | 168 |
Income After Depreciation & Amortization | 96 | 938 | 1,233 | 227 | 232 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 72.78 | 75.40 | 79.56 | 80.15 | 81.43 |
Diluted EPS Before Non-Recurring Items | 3.02 | 8.63 | 14.39 | 1.91 | 2.04 |
Diluted Net EPS (GAAP) | 3.02 | 8.73 | 14.39 | 2.50 | 2.04 |
Fiscal Year end for Aperam falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 1,758.85 | 1,799.09 | 1,670.11 | 1,592.30 | 1,852.78 |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | 63.51 | -20.63 | 75.38 | -45.71 | 46.81 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 63.51 | -20.63 | 75.38 | -45.71 | 46.81 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 72.79 | 72.63 | 72.78 | 72.78 | 71.67 |
Diluted EPS Before Non-Recurring Items | 0.88 | -0.35 | 1.03 | -0.63 | 0.63 |
Diluted Net EPS (GAAP) | 0.88 | -0.28 | 1.03 | -0.63 | 0.63 |